Summary of "18. What Happens When Things Go Wrong: Mental Illness, Part I"

Concise summary of main ideas, concepts and lessons

1) What counts as “abnormal”

There is no blood test or single biological marker for mental disorders. Diagnosis is based on behavioral criteria (symptoms reported by people and observed by clinicians) plus a clinical judgment that can be subjective.
Diagnosis is shaped by social and cultural norms, individual characteristics (e.g., gender stereotypes), and context (what is adaptive in one situation may be maladaptive in another).
Clinical heuristic: the “three Ds” (used to evaluate abnormality)

Distress: significant suffering experienced by the person or others. Dysfunction: symptoms interfere with daily functioning (work, school, relationships). Deviance: behavior is unusual for the culture (controversial because it is culture-dependent).

2) Diagnostic system

The DSM (Diagnostic and Statistical Manual; DSM-IV at time of lecture) provides symptom lists, required symptoms, and duration criteria to guide diagnoses.
Despite structured criteria, diagnosis still involves judgment calls by clinicians.

3) Mood disorders — overview and epidemiology

Two broad categories:
- Unipolar depressive disorders (major depression)
- Bipolar disorders (cycles of mania and depression)
Prevalence and demographic patterns:
- Major depression: common — roughly 25% of women and ~13% of men will have a serious episode in their lifetime. Onset peaks in late adolescence/college years. Average untreated major depressive episode lasts about 6 months (DSM minimum criterion = 2 weeks).
- Bipolar disorder: about 1% lifetime prevalence; equal in men and women. Peak onset in late teens/early 20s.
- Age: highest rates in ages 15–24; rates appear lower in the elderly (reasons debated).
- Gender: before puberty rates are similar in boys and girls; after puberty females have about twice the rate of depressive symptoms and disorders compared with males.

4) DSM criteria — Major Depressive Episode

Required: either

depressed mood, or
markedly diminished interest/pleasure (anhedonia)

Plus at least four of the following (present nearly daily and for at least 2 weeks total):

Significant weight or appetite change (loss or binge-eating/weight gain)
Sleep disturbance (insomnia or hypersomnia; early-morning awakening common)
Psychomotor retardation or agitation (retardation more common — slowed speech, movement)
Fatigue or loss of energy
Feelings of worthlessness or excessive/inappropriate guilt (may become psychotic with guilt-themed delusions)
Diminished concentration or indecisiveness
Suicidal ideation or behavior

Clinical points:

Depression exists on a continuum from normal sadness to severe, nonfunctional states.
Many people continue daily functioning despite symptoms (“walking wounded”).

5) Mania / Bipolar — key criteria

Required:

Abnormally elevated, expansive, or irritable mood for at least one week (more than a transient “good day”).

Plus three or more of:

Inflated self-esteem or grandiosity
Decreased need for sleep
Pressured speech / increased talkativeness and flight of ideas
Distractibility
Increased goal-directed activity or psychomotor agitation
Excessive involvement in pleasurable but risky activities (sexual indiscretions, spending sprees, gambling, substance use)

Notes:

Mania ranges from mild to severe/psychotic (delusions are typically grandiose).
The pleasurable elements of mania may delay help-seeking; harm or a subsequent depressive plunge often prompt treatment.

6) Biological theories and evidence

Genetics:
- Bipolar disorder: strong genetic contribution (monozygotic twin concordance >60% vs dizygotic ~12%).
- Major depression: genetic signals are stronger for early-onset cases; life-event–triggered depression may be less heritable.
Neurotransmitters:
- Monoamines (serotonin, norepinephrine, dopamine) implicated.
- Current thinking emphasizes receptor function and complex regulation rather than a simple “low serotonin” explanation.
Gene × environment interaction:
- Studies (e.g., Caspi et al.) suggest certain serotonin transporter gene variants (short allele) increase risk of depression following major stress or maltreatment — genes typically increase vulnerability but do not determine outcome alone.
Brain regions implicated:
- Prefrontal cortex: reduced activity (linked to executive dysfunction, concentration, regulation)
- Amygdala: hyperactivity to emotional stimuli
- Hippocampus: volume reductions in chronic depression (memory/concentration effects)
- Anterior cingulate: dysregulation related to stress response and behavioral choice

7) Treatments — biological and psychosocial

Pharmacological

Older antidepressants: MAO inhibitors, tricyclics — about 60% respond but have significant side effects; tricyclics are dangerous in overdose.
SSRIs (e.g., Prozac, Paxil) and SNRIs: widely used, fewer side effects, similar efficacy to older drugs for many patients but not universally effective.
Lithium: mainstay mood stabilizer for bipolar disorder (effective but with side effects and teratogenic risks; may not fully relieve depressive poles).
Antipsychotics: used when psychotic symptoms are present.

Psychotherapies

Cognitive Behavioral Therapy (CBT — Aaron Beck)
- Core theory: a negative cognitive triad (negative views of self, world, future) is maintained by cognitive distortions (all-or-nothing thinking, emotional reasoning, personalization).
- Typical methods:
  - Identify negative automatic thoughts and themes
  - Evaluate and challenge evidence for these thoughts; generate alternative, balanced interpretations
  - Behavioral activation and problem-solving to change situations that maintain depression
  - Teach mood-management and anticipatory coping strategies
  - Emphasize homework and practice between sessions (structured, short-term, skills-based)
- Evidence: randomized studies show CBT is roughly as effective as SSRIs in acute treatment (example: 16-week parity). CBT also reduces relapse rates substantially when compared to medication discontinuation.
Interpersonal Therapy (IPT)
- Focuses on early relationships and recurring interpersonal patterns that create negative self-views and relationship problems.
- Less structured and somewhat more past-oriented than CBT; effective for many patients, especially when relationship themes are central.

Combination and clinical choice

Multiple effective options exist (medication, CBT, IPT, and combinations). Treatment selection considers symptom profile, history, comorbidity, and patient preference.

8) Practical lessons and clinical implications

Effective treatments exist — people do not need to “stay depressed.”
CBT not only treats acute episodes but reduces relapse risk by teaching coping skills.
Clinicians must apply judgment, taking into account cultural and contextual factors since diagnosis is partly subjective.
Gene × environment findings underscore that genetic risk usually requires stress or trauma to precipitate disorder.

Methodological notes (research and diagnostic approaches)

Diagnosis in practice: match reported symptoms and observed behavior to DSM criteria; clinician judgment about severity, dysfunction, and cultural/contextual norms is essential.
Genetic studies: twin concordance and family aggregation studies are used to estimate heritability.
Gene × environment research: examines interaction effects (specific alleles × exposure to stressors) predicting onset.
Treatment outcome research: randomized controlled trials compare psychotherapy, medication, and placebo, with follow-ups to measure relapse rates.

Speakers and sources featured

Professor Paul Bloom (introducer)
Professor Susan Nolen-Hoeksema (primary lecturer)
Tara (woman in video clip describing severe depressive episodes)
Bernie (man in video clip with bipolar disorder history)
Avshalom Caspi (researcher cited for serotonin transporter gene × stress study)
Kay Jamison (author/researcher about mania in historical figures)
Julia Kim-Cohen (researcher at Yale mentioned)
Joan Kaufman (researcher mentioned)
Aaron Beck (originator of cognitive therapy)
Aaron Beck’s daughter (therapist demonstrating/role-playing CBT in a clip)
DSM (Diagnostic and Statistical Manual, referenced as DSM-IV)
Medications and classes referenced: Prozac, Paxil, SSRIs, SNRIs, tricyclics, MAOIs, lithium, antipsychotics